| | |
| 0859 |
11:00 AM | Evaluation of H2-Receptor Antagonists- Cimetidine, Ranitidine and Famotidine in an In-vivo Gingivitis Model
A.G. SNIDER, The Procter and Gamble Company, Mason, OH, USA, J.P. EBEL, H.M. PICKRUM, USA, and R.E. SINGER |
| 0860 |
11:15 AM | Gingival Hyperplasia Substituting an Alternative Anti-Seizure Regimen for Dilantin®
E. WARR1, H.D. HOOD2, M. GRUENTHAL3, and A.G. FARMAN1, 1University of Louisville School of Dentistry, KY, USA, 2Hazelwood Center, Louisville, KY, USA, 3University of Louisville School of Medicine, KY, USA |
| 0861 |
11:30 AM | Genetic Susceptibility Factors For Cyclosporin Induced Gingival Overgrowth In Renal Transplant Patients
S.E. HAWORTH1, K.V. POULTON1, P.A. DYER1, C.D. SHORT1, P.S. HULL2, and J.A. JAMES2, 1Manchester Institute of Nephrology and Transplantation, United Kingdom, 2University Dental Hospital of Manchester, United Kingdom |
| 0862 |
11:45 AM | Nicotine Effects on T Cell Proliferation and Interleukin-6 Production
S. ZHANG, R.L. GREGORY, and B.L. OLSON, Indiana University School of Dentistry, Indianapolis, USA |
| 0863 |
12:00 PM | Roles for NF-kB and Caspase Activation in Osteoblastic Cell Cycle
N. OZEKI, M. MOGI, H. NAKAMURA, and A. TOGARI, School of Dentistry, Aichi-Gakuin University, Nagoya, Japan |
| 0864 |
12:15 PM | Reduction of Tumor Cell Protease Expression by Chemically Modified Tetracyclines
Y. GU, M. KOTHARI, H.M. LEE, E. ROEMER, L. GOLUB, and S.R. SIMON, State University of New York at Stony Brook, USA |
| 0865 |
12:30 PM | Candida albicans Switch Phenotypes Uptake Fluconazole Differentially
R. SRIKANTHA, A. HOLKE, and K. VARGAS, The University of Iowa, Iowa City, USA |
| 0866 |
12:45 PM | Lipid-mediated Gene Delivery to HSC-3 and HEK293 Cells in the Presence of Serum
A. LIM, A. LEE, K. KONOPKA, and N. DÜZGÜNES, University of the Pacific School of Dentistry, San Francisco, CA, USA |
| 0867 |
1:00 PM | Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition
S.H. KIM1, Y.G. KIM2, M.K. CHO2, S.G. KIM2, M.G. LEE2, and J.W. KWON3, 1Kangnung National University, South Korea, 2Seoul National Univerity, South Korea, 3Dong-A Pharmaceuticl Company, Ltd, Yongin, South Korea |
| 0868 |
1:15 PM | Effect of meloxicam on tissue and serum concentrations of amoxicillin during experimental infection in rats
A.P.D.B. RUENIS, F.C. GROPPO, V.A. KARLOWSKI, Jr., F.D.S. DEL FIOL, R.P. SIMõES, and P.L. ROSALEN, Faculty of Dentistry of Piracicaba / UNICAMP, Brazil |
| 0869 |
1:30 PM | The insulin-like growth factor (IGF) system in squamous cell carcinomas of the pharynx and oral cavity
M.M. KIBBEY, M.J. JAMESON, and S.A. ROSENZWEIG, Medical University of South Carolina, Charleston, USA |
| 0870 |
1:45 PM | Lysophosphatidic acid and PDGF interact to stimulate growth of PDL fibroblasts in an in vitro wound healing model
A. DREYER, TBD, Omaha, NE, USA, F. CORDINI, T.P. MCVANEY, J.S. MATTSON, and D.R. CERUTIS |
| 0871 |
2:00 PM | Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20) but not urokinase-type plasminogen activator (uPA) and diminish invasion and migration of human malignant and endothelial cell lines
P. HEIKKILÄ, Helsinki, Finland, O. TERONEN, M. MOILANEN, Y.T. KONTTINEN, R. HANEMAAIJER, M. LAITINEN, P. MAISI, V.D.G. PLUIJM, J.D. BARTLETT, T. SALO, and T. SORSA |
|